Escherichia coli is the major causative agent for urinary tract infections (UTIs), and fluoroquinolones (FQ) are commonly used in the treatment of patients with UTIs. The surge in FQ-resistant E. coli is an important public health threat worldwide. We investigated the prevalence and mechanisms of FQ resistance among FQ-resistant E. coli isolated from UTI patients. A total of 131 FQ-resistant E. coli strains were characterized and broth microdilution assay showed that 108 strains (82.4%) were highly resistant to ciprofloxacin (MIC ≥ 32 μg/mL). All strains were analyzed for plasmid-mediated quinolone resistance (PMQR) genes, with 37 (28.2%) testing positive. Among the PMQR genes detected, aac(6’)-Ib-cr was the most frequent, found in 30 strains (22.9%), followed by qnrS in 10 strains (7.6%) and qnrB in 1 strain (0.8%). PCR assay showed that all carried acrA, acrB, and tolC genes, but 33 strains (25.2%) revealed at least 4-fold reduction in ciprofloxacin MIC when using PAβN and CCCP as efflux pump inhibitors, indicating the role of the AcrAB efflux pump in ciprofloxacin resistance in these strains. The 19 strains of high-level ciprofloxacin-resistant E. coli were selected to determine the target enzyme alteration by PCR assay and DNA sequencing. Genetic analysis revealed that 16 strains (84.2%) had double mutations in gyrA (S83L and D87 to N or Y) with single mutation in parC (S80I), while 3 strains (15.8%) had double mutations in gyrA (S83L and D87 to N or Y) and parC (S80I and E84 to G or V). The positive efflux activity was linked to increased MIC values of ciprofloxacin (P < 0.001). Overall, the carriage of PMQR genes, efflux activity, and target mutations across E. coli strains contribute to ciprofloxacin resistance, a result that may necessitate a reassessment of the antibiotics in use for empirical UTIs therapy.
Drug‐resistant infections, such as colistin resistance, are reportedly increasing due to the inappropriate use of antibiotics, lack of good control, and the use of excessive quantities of antibiotics. Colistin resistance has been observed in bacteria of the order Enterobacterales exhibiting resistance to third‐generation cephalosporins or carbapenems. Currently, the prevalence of colistin resistance in third‐generation cephalosporin‐resistant E. coli obtained from patients at Nopparat Rajathanee Hospital, Thailand, in 2023 was determined by broth microdilution. Among 343 isolates, 1.45% (95% CI: 0.19%–2.73%, n = 5/343) exhibited a minimum inhibitory concentration (MIC) of colistin between 4 and 8 μ g/mL, indicating colistin‐resistant E. coli . Nevertheless, five isolates were positive for resistant genes by multiplex PCR: two isolates for mcr ‐1, two isolates for mcr ‐3, and one isolate for both mcr ‐1 and mcr ‐3. This study reveals crucial data on resistance genes, informing surveillance of antibiotic resistance, treatment decisions, and public health initiatives to combat resistant bacteria.
1 January 2025 in Journal of Parasitology Research
This is a cross‐sectional study that is aimed at evaluating the efficacy of antilice shampoo against head lice infestation in primary schoolgirls at level 3–6 (aged between 9 and 12 years) with a high prevalence of infestation in Pathum Thani Province and which also reported a current prevalence of lice infestation in this school. The study was conducted during January–March 2023. A total of 356 schoolchildren were screened for lice infestation. The prevalence rate of lice infestation was found in 78 students (21.9%) from all schoolchildren. Girls (50.3%) showed a higher rate of lice infestation than boys (0.5%) with a significant difference ( p < 0.05). Most lice‐infested girls (100%) reported itching. Seventy‐two of 77 infested girls (93.5%) agreed to use shampoos for lice treatment. Two types of commercial shampoos were considered for lice treatment: (1) chemical (permethrin 0.5% W/V) antilice shampoo and (2) herbal antilice shampoo, since it is cheap and available in the market. The results of chemical (permethrin 0.5% W/V) antilice shampoo showed similar efficacy for lice treatment as herbal antilice shampoo with no significant difference in statistics ( p > 0.05). Using the antilice shampoos consecutively 3 times demonstrated the highest efficacy of treatment (73.0%), followed by 2 times (34.3%), and the lowest efficacy of treatment was a single application (5.6%). No serious side effects from both shampoos in participants: 2 cases of itching and 1 case of the burning sensation. This indicated that in the area of the high prevalence of lice infestation, herbal antilice shampoo might be an alternative choice for lice treatment. However, we recommended using it once a week 3 times consecutively to reach the highest efficacy for treatment. In addition, this treatment should be extended to family members with lice infestation.